SCHEMBL2994385

SCHEMBL2994385

CCOc1cc(-c2sc(N)c3c2C(=O)N(CCC(=O)OC)C3=O)ccc1OC

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.42
PDE4A P27815 3/20 0.41
PDE4B Q07343 3/20 0.41
PDE4C Q08493 3/20 0.41
PDE4D Q08499 3/20 0.41
CASP3 P42574 3/20 0.39
MEN1 O00255 1/20 0.38
KMT2A Q03164 1/20 0.38
PIK3CD O00329 1/20 0.38
ABL1 P00519 1/20 0.38
EGFR P00533 1/20 0.38
HCK P08631 1/20 0.38
SRC P12931 1/20 0.38
KDR P35968 1/20 0.38
PIK3CA P42336 1/20 0.38
PIK3CB P42338 1/20 0.38
MTOR P42345 1/20 0.38
PIK3CG P48736 1/20 0.38
EPHB4 P54760 1/20 0.38
PRKDC P78527 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2995635 0.96 ALDH1A1 (0.42) ALDH1A1PDE4APDE4BPDE4CPDE4D
SCHEMBL2997216 0.93 CASP3 (0.42) ALDH1A1PDE4APDE4BPDE4CPDE4D
SCHEMBL2998875 0.89 CASP3 (0.38) ALDH1A1CASP3MEN1KMT2AKDM4E
SCHEMBL2996891 0.84 ABCB1 (0.49) ALDH1A1CASP3SMN1; SMN2HPGDHSD17B10
SCHEMBL2987999 0.84 PDE4B (0.48) PDE4APDE4BPDE4CPDE4D
SCHEMBL2999671 0.83 PDE4B (0.42) ALDH1A1PDE4APDE4BPDE4CPDE4D
SCHEMBL2993145 0.80 ALDH1A1 (0.42) ALDH1A1PDE4APDE4BPDE4CPDE4D
SCHEMBL2989819 0.77 TSHR (0.41) ALDH1A1PDE4APDE4BPDE4CPDE4D
SCHEMBL2995604 0.76 TSHR (0.41) ALDH1A1PDE4APDE4BPDE4CPDE4D
SCHEMBL2994679 0.76 LMNA (0.44) ALDH1A1CASP3KDM4EHPGDHSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100179189-A1 PYRROLINE DERIVATIVES AGAINST CELL RELEASING TUMOR NECROSIS FACTOR, PREPARATION METHODS AND USES THEREOF ZHANG HESHENG 2010-07-15 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100179189-A1 PYRROLINE DERIVATIVES AGAINST CELL RELEASING TUMOR NECROSIS FACTOR, PREPARATION METHODS AND USES THEREOF TNF, IL1B, NOS1 ALDH1A1 1039/4885PDE4A 2306/4885PDE4B 2498/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.